Resistance to carbapenems among Pseudomonas aeruginosa isolated from patients of transplant wards. 2009

G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
Department of Medical Microbiology, Transplantology and Internal Diseases of Transplantation Institute, The Medical University of Warsaw, Chalubinskiego 5 02-004 Warsaw, Poland. grazyna.mlynarczyk@wum.edu.pl

BACKGROUND The aim of the study was to estimate the carbapenems resistance and occurrence of metallo-beta-lactamase (MBL) production among Pseudomonas aeruginosa isolated from patients during the last 2 years. METHODS We investigated all P aeruginosa strains derived from Transplantation Institute patients, hospitalized from January 2007 to December 2008. E-tests as well as the three-discs method with imipenem, ceftazidime were used for MBL detection. For the chosen strains, a PCR method was applied for detection of genes determining VIM, IMP, and SMP. RESULTS Among 311 isolated strains from 228 patients only one strain was used for each patient. We showed increased resistance to carbapenems among P aeruginosa in 2008 compared with 2007: from 14% to 22%. About 60% of resistant strains displayed the MBL phenotype. Upon PCR analysis, the VIM-type metallo-beta-lactamase was detected in 70% of them. CONCLUSIONS Despite similar numbers of P aeruginosa-infected patients in 2007 and 2008, the percentage of MBL-producing strains increased from 7% to 15%. Most MBLs belonged to the VIM type.

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D014180 Transplantation Transference of a tissue or organ from either an alive or deceased donor, within an individual, between individuals of the same species, or between individuals of different species. Transplantations
D015780 Carbapenems A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain. Antibiotics, Carbapenem,Carbapenem,Carbapenem Antibiotics
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017931 DNA Primers Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques. DNA Primer,Oligodeoxyribonucleotide Primer,Oligodeoxyribonucleotide Primers,Oligonucleotide Primer,Oligonucleotide Primers,Primer, DNA,Primer, Oligodeoxyribonucleotide,Primer, Oligonucleotide,Primers, DNA,Primers, Oligodeoxyribonucleotide,Primers, Oligonucleotide
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
January 2017, Frontiers in microbiology,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
April 1999, Journal of chemotherapy (Florence, Italy),
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
September 2011, The Journal of hospital infection,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
January 2019, Infection and drug resistance,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
February 2014, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
January 2018, Journal of infection in developing countries,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
June 1984, American journal of clinical pathology,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
March 2018, International journal of antimicrobial agents,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
January 2013, Advances in experimental medicine and biology,
G Mlynarczyk, and A Sawicka-Grzelak, and K Szymanek, and T Buczkowska, and J Pazik, and M Durlik, and M Pacholczyk, and B Lagiewska, and A Chmura, and L Paczek, and A Mlynarczyk
October 1991, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!